Cargando…
Expression of FGF8, FGF18, and FGFR4 in Gastroesophageal Adenocarcinomas
Even though distinctive advances in the field of esophageal cancer therapy have occurred over the last few years, patients’ survival rates remain poor. FGF8, FGF18, and FGFR4 have been identified as promising biomarkers in a number of cancers; however no data exist on expression of FGF8, FGF18, and...
Autores principales: | Jomrich, Gerd, Hudec, Xenia, Harpain, Felix, Winkler, Daniel, Timelthaler, Gerald, Mohr, Thomas, Marian, Brigitte, Schoppmann, Sebastian F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770911/ https://www.ncbi.nlm.nih.gov/pubmed/31527546 http://dx.doi.org/10.3390/cells8091092 |
Ejemplares similares
-
FGF8 induces therapy resistance in neoadjuvantly radiated rectal cancer
por: Harpain, Felix, et al.
Publicado: (2018) -
Platelets as a prognostic factor for patients with adenocarcinoma of the gastroesophageal junction
por: Feka, Joy, et al.
Publicado: (2023) -
High Mean Corpuscular Volume Predicts Poor Outcome for Patients With Gastroesophageal Adenocarcinoma
por: Jomrich, Gerd, et al.
Publicado: (2019) -
Differential Specificity of Endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in Complex with KLB
por: Yang, Chaofeng, et al.
Publicado: (2012) -
Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity
por: Agrawal, Archita, et al.
Publicado: (2018)